Medical Co-Morbidity in Schizophrenia from Rural Region of Central India: A Cross-Sectional Study

Background: Patients with schizophrenia have higher mortality and shorter life expectancy. The main reasons for high mortality rates are medical problems, unhealthy lifestyles, substance abuse, compliance compliance or treatment refusal, and unnatural causes of suicide. The average person diagnosed with schizophrenia is 9 to 12 years younger than the average age of the general population. OBJECTIVES: Prevalence of medical co-morbidity; to examine the association between medical comorbidities in schizophrenia patients and social demographic and clinical variables; and to determine the relevance of I. C. D. - 10 Schizophrenia subtype and medical complications. Materials and Methods: A 100-month cross-sectional study of 100 patients was conducted according to inclusion and exclusion criteria as defined by the tertiary medical center. A semi-structured format designed for this study was used to gather social demographic and clinical details. RESULTS: 22% of the patients reported complications associated with the disease. The most common disability is endocrinopathy (31.82%). Elderly patients taking psychotropics were significantly associated (p <0.05) with medical co-morbidity and were significantly associated with drug use history (p <0.05). Conclusion: The prevalence of medical complications is 22%, which is lower than previous literature. Sometimes, the physical disorder of these patients is yet to be recognized, so the integrated approach requires prevention and treatment.

In short, schizophrenia and the cognitive ability of diabetic patients are severely affected. Schizophrenia with complicated diabetes mellitus shows schizophrenia without diabetes mellitus and severe cognitive impairment more than diabetes alone, especially in immediate memory and attention, and shows cumulative impairment in schizophrenia and diabetes mellitus. Effect However, due to the nature of the cross-sectional design in our research, synergistic effects may be related to a wide range of hippocampal abnormalities caused by abnormal glucose metabolism, but we have reasonable explanation for this additive effect Can not be provided.

Background: Patients with schizophrenia have higher mortality and shorter life expectancy. The main reasons for high mortality rates are medical problems, unhealthy lifestyles, substance abuse, compliance compliance or treatment refusal, and unnatural causes of suicide. The average person diagnosed with schizophrenia is 9 to 12 years younger than the average age of the general population. OBJECTIVES: Prevalence of medical co-morbidity; to examine the association between medical comorbidities in schizophrenia patients and social demographic and clinical variables; and to determine the relevance of I. C. D. - 10 Schizophrenia subtype and medical complications. Materials and Methods: A 100-month cross-sectional study of 100 patients was conducted according to inclusion and exclusion criteria as defined by the tertiary medical center. A semi-structured format designed for this study was used to collect social demographic and clinical details

Salavanan B, et al. "A belief model in the first schizophrenia in southern India", schizophrenic people in this region of India influenced patterns of health, and various non-potential Due to the lack of insight we conclude to hold medical belief models. Bhugra D explains "Saty: non psychotic suicide" and explains the cultural factors that are thought to lead to suicidal behavior. Loganathan and Murthy SR studied 'experiences of stigma and discrimination in schizophrenic patients' and found that there was a significant difference between rural and urban respondents. They concluded that mental health programs and policies are sensitive to consumer needs, organize services, and effectively reduce stigma and discrimination. Gautam S et al